| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 30, 2022 | Post-IPO Equity | €102.90M | 2 | — | — | Detail |
| Jun 20, 2022 | Post-IPO Equity | €90.50M | 1 | Pfizer | — | Detail |
| Apr 26, 2022 | Post-IPO Debt | $20M | 2 | Deepfield , OrbiMed | — | Detail |
| Feb 21, 2022 | Grant | £20M | 1 | Scottish Enterprise | — | Detail |
| Nov 1, 2021 | Post-IPO Equity | €88M | — | — | — | Detail |
| May 6, 2021 | IPO | $107.60M | — | — | — | Detail |
| Feb 3, 2020 | Post-IPO Debt | $85M | — | — | — | Detail |
| Sep 27, 2018 | Post-IPO Equity | €50M | — | — | — | Detail |
| Dec 15, 2016 | Post-IPO Equity | €15.20M | — | — | — | Detail |
| Jul 12, 2016 | Post-IPO Debt | €25M | — | — | — | Detail |
| Feb 4, 2015 | Post-IPO Equity | €45M | — | — | — | Detail |
| Dec 9, 2013 | Post-IPO Debt | €30M | — | — | — | Detail |
| Jun 13, 2013 | Post-IPO Equity | €40.20M | — | — | — | Detail |